Capricor Therapeutics reported $7.32M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Bluebird Bio BLUE:US $ 108.92M 13.37M
Capricor Therapeutics CAPR:US $ 7.32M 509.78K
Cytokinetics CYTK:US $ 99.84M 18.14M
Cytori Therapeutics CYTX:US $ 5.12M 1.19M
Geron GERN:US $ 28.05M 749K
Johnson & Johnson JNJ:US $ 18.18B 616M
Newlink Genetics NLNK:US 8.33M 485K
Prothena PRTA:US 44.52M 5.42M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Vital Therapies VTL:US $ 20.61M 825K